Cannabinoid receptor activation in the rostral ventrolateral medulla oblongata evokes cardiorespiratory effects in anaesthetised rats

British Journal of Pharmacology

Volumn 140, Issue 2, 2003, Pages 384-394

  Padley, James R ^a,b   Li, Qun ^a,b   Pilowsky, Paul M ^a,b   Goodchild, Ann K ^a,b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Apnoea; Cannabinoid; Cardiorespiratory; CB 1; Rostral ventrolateral medulla; Sympathoexcitation

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; DEXANABINOL; DRONABINOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; ATTENUATION; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEART RATE VARIABILITY; IMMOBILIZATION STRESS; INJECTION SITE; LATENT PERIOD; MEAN ARTERIAL PRESSURE; MEDULLA OBLONGATA; MICROINJECTION; NERVE CELL EXCITABILITY; NERVE CONDUCTION; NONHUMAN; PHRENIC NERVE; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; RESPIRATORY FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHOMBENCEPHALON; SPLANCHNIC NERVE; THALAMUS VENTRAL NUCLEUS;

ANESTHESIA; ANIMALS; BLOOD PRESSURE; CANNABINOIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HEART RATE; LIGANDS; MALE; MEDULLA OBLONGATA; MICROINJECTIONS; MORPHOLINES; NAPHTHALENES; NEUROPROTECTIVE AGENTS; PHRENIC NERVE; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RESPIRATORY MECHANICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPLANCHNIC NERVES; TETRAHYDROCANNABINOL;

EID: 0141923030     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705422     Document Type: Article

References (52)

1. BENOWITZ, N.L. & JONES, R.T. (1975). Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clin. Pharmacol. Ther., 18, 287-297.
2. BENOWITZ, N.L., ROSENBERG, J., ROGERS, W., BACHMAN, J. & JONES, R.T. (1979). Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: autonomic nervous mechanisms. Clin. Pharmacol. Ther., 25, 440-446.
3. BIANCHI, A.L., DENAVIT-SAUBIE, M. & CHAMPAGNAT, J. (1995). Central control of breathing in mammals: neuronal circuitry, membrane properties, and neurotransmitters. Physiol. Rev., 75, 2-45.
4. BREIVOGEL, C.S., GRIFFIN, G., DI MARZO, V. & MARTIN, B.R. (2001). Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol. Pharmacol., 60, 155-163.
5. BREIVOGEL, C.S., SIM, L.J. & CHILDERS, S.R. (1997). Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J. Pharmacol. Exp. Ther., 282, 1632-1642.
6. CHITRAVANSHI, V.C. & SAPRU, H.N. (1999). Phrenic nerve responses to chemical stimulation of the subregions of ventral medullary respiratory neuronal group in the rat. Brain Res., 821, 443-460.
7. COSENZA, M., GIFFORD, A.N., GATLEY, J., PYATT, B., LIU, Q., MAKRIYANNIS, A. & VOLKOW, N.D. (2000). Locomotor activity and occupancy of brain cannabinoid CB1 receptors by the antagonist/inverse agonist AM281. Synapse, 38, 477-482.
8. DOHERTY, P.A., McCARTHY, L.E. & BORISON, H.L. (1983). Respiratory and cardiovascular depressant effects of nabilone, N-methyllevonantradol and delta-9-tetrahydrocannabinol in anaesthetised cats. J. Pharmacol. Exp. Ther., 227, 508-516.
9. ESTRADA, U., BRASE, D.A., MARTIN, B.R. & DEWEY, W.L. (1987). Cardiovascular effects of delta-9- and delta-9(11)-tetrahydrocannabinol and their interaction with epinephrine. Life Sci., 41, 79-87.
10. EZURE, K. (1990). Synaptic connections between medullary respiratory neurons and considerations on the genesis of respiratory rhythm. Prog. Neurobiol., 35, 429-450.
11. GARDINER, S.M., MARCH, J.E., KEMP, P.A. & BENNETT, T. (2001). Regional haemodynamic responses to the cannabinoid agonist, WIN55,212-2, in conscious, normotensive rats, and in hypertensive, transgenic rats. Br. J. Pharmacol., 133, 445-453.
12. GARDINER, S.M., MARCH, J.E., KEMP, P.A. & BENNETT, T. (2002). Influence of the CB1 receptor antagonist, AM251, on the regional haemodynamic effects of WIN55,212-2 or HU-210 in conscious rats. Br. J. Pharmacol., 136, 581-587.
13. GATLEY, S.J., LAN, R., VOLKOW, N.D., PAPPAS, N., KING, P., WONG, C.T., GIFFORD, A.N., PYATT, B., DEWEY, S.L. & MAKRIYANNIS, A. (1998). Imaging the brain marijuana receptor: development of a radioligand that binds to cannabinoids CB1 receptors in vivo. J. Neurochem., 70, 417-423.
14. GERAGHTY, D.P. & MAZZONE, S.B. (2002). Respiratory actions of vanilloid receptor agonists in the nucleus of the solitary tract: comparison of resiniferotoxin with non-pungent agents and anandamide. Br. J. Pharmacol., 137, 919-927.
15. GIFFORD, A.N., BRUNEUS, M., GATLEY, S.J., LAN, R.X., MAKRIYANNIS, A. & VOLKOW, N.D. (1999). Large receptor reserve for cannabinoid actions in the central nervous system. J. Pharmacol. Exp. Ther., 288, 478-483.
16. GRAHAM, J.D. & LI, D.M. (1973). Cardiovascular and respiratory effects of cannabis in cat and rat. Br. J. Pharmacol., 49, 1-10.
17. HERKENHAM, M., LYNN, A.B., JOHNSON, M.R., MELVIN, L.S., DE COSTA, B.R. & RICE, K.C. (1991). Characterisation and localisation of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci., 11, 563-583.
18. HILLARD, C.J. (2000). Endocannabinoids and vascular function. J. Pharmacol. Exp. Ther., 294, 27-32.
19. HOWLETT, A.C., BARTH, F., BONNER, T.I., CABRAL, G., CASELLAS, P., DEVANE, W.A., FELDER, C.C., HERKENHAM, M., MACKIE, K., MARTIN, B.R., MECHOULAM, R. & PERTWEE, R.G. (2002). International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev., 54, 161-202.
20. ISHAC, E.J.N., JIANG, L., LAKE, K.D., VARGA, K., ABOOD, M.E. & KUNOS, G. (1996). Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br. J. Pharmacol., 118, 2023-2028.
21. JANDHYALA, B.S. & HAMED, A.T. (1978). Pulmonary and systemic hemodynamic effects of delta9-tetrahydrocannabinol in conscious and morphine-chloralose-anaesthetised dogs: anesthetic influence on drug action. Eur. J. Pharmacol., 53, 63-68.
22. KANJHAN, R., LIPSKI, J., KRUSZEWSKA, B. & RONG, W. (1995). A comparative study of pre-sympathetic and Botzinger neurons in the rostral ventrolateral medulla (RVLM) of the rat. Brain Res., 699, 19-32.
23. KAWASAKI, H., WATANABE, S., OISHI, R. & UEKI, S. (1980). Effects of delta-9-tetrahydrocannabinol on the cardiovascular system, and pressor and behavioral responses to brain stimulation in rats. Jpn. J. Pharmacol., 30, 493-502.
24. LAKE, K.D., COMPTON, D.R., VARGA, K., MARTIN, B.R. & KUNOS, G. (1997a). Cannabinoid-induced hypotension and bradycardia in rats is mediated by CB1-like cannabinoid receptors. J. Pharmacol. Exp. Ther., 281, 1030-1037.
25. LAKE, K.D., MARTIN, B.R., KUNOS, G. & VARGA, K. (1997b). Cardiovascular effects of anandamide in anesthetised and conscious normotensive and hypertensive rats. Hypertension, 29, 1204-1210.
26. LEDENT, C., VALVERDE, O., COSSU, G., PETITET, F., AUBERT, J.F., BESLOT, F., BOHME, G.A., IMPERATO, A., PEDRAZZINI, T., ROQUES, B.P., VASSART, G., FRATTA, W. & PARMENTIER, M. (1999). Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science, 283, 401-404.
27. LI, Q., GOODCHILD, A.M. & PILOWSKY, P.M. (2003). The effect of haemorrhage on neurotransmitter-related genes in rat ventrolateral medulla: a quantitative real-time-RT-PCR study. Mol. Brain Res., 114, 46-54.
28. MAILLEUX, P., PARMENTIER, M. & VANDERHAGEN, J.J. (1992). Distribution of cannabinoid receptor messenger RNA in the human brain: an in situ hybridization histochemistry with oligonucleotides. Neurosci. Lett., 143, 200-204.
29. MARTIN, W.J., TSOU, K. & WALKER, J.M. (1998). Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla. Neurosci. Lett., 242, 33-36.
30. MATSUDA, L.A., BONNER, T.I. & LOLAIT, S.J. (1993). Localisation of cannabinoid receptor mRNA in rat brain. J. Comp. Neurol., 327, 535-550.
31. MATSUDA, L.A., LOLAIT, S.J., BROWNSTEIN, M.J., YOUNG, A.C. & BONNER, T.I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564.
32. MILLIGAN, G. & BOND, R.A. (1997). Inverse agonism and the regulation of receptor number. Trends Pharmacol. Sci., 18, 468-474.
33. MIYAWAKI, T., GOODCHILD, A.K. & PILOWSKY, P.M. (2003). Maintenance of sympathetic tone by a nickel chloride sensitive mechanism in the rostral ventrolateral medulla of the adult rat. Neuroscience, 116, 455-464.
34. MUNRO, S., THOMAS, K.L. & ABU-SHAAR, M. (1993). Molecular characterisation of a peripheral receptor for cannabinoids. Nature, 365, 61-65.
35. NIEDERHOFFER, N., SCHMID, K. & SZABO, B. (2001). Analysis of the cardiovascular depressive effects of cannabinoids in anaesthetised rats (abstract). Naunyn-Schmiedeberg's Arch. Pharmacol., 363, R27.
36. NIEDERHOFFER, N. & SZABO, B. (1999). Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation. Br. J. Pharmacol., 126, 457-466.
37. NIEDERHOFFER, N. & SZABO, B. (2000). Cannabinoids cause central sympathoexcitation and bradycardia in rabbits. J. Pharmacol. Exp. Ther., 294, 707-713.
38. ONAIVI, E.S., LEONARD, C.M., ISHIGURO, H., ZANG, P.W., LIN, Z., AKINSHOLA, B.E. & UHL, G.R. (2002). Endocannabinoid and receptor genetics. Prog. Neurobiol., 567, 1-38.
39. PAXINOS, G. & WATSON, C. (1986). The Rat Brain in Stereotaxic Coordinates, 2nd edn. London: Academic Press.
40. PILOWSKY, P.M. (1995). Good vibrations? Respiratory rhythms in the central control of blood pressure. Clin. Exp. Pharmacol. Physiol., 22, 594-604.
41. PILOWSKY, P.M. & GOODCHILD, A.K. (2002). Baroreceptor reflex pathways and neurotransmitters: 10 years on. J. Hypertens., 20, 1675-1688.
42. PILOWSKY, P.M., JIANG, C. & LIPSKI, J. (1990). An intracellular study of respiratory neurons in the rostral ventrolateral medulla of the rat and their relationship to catecholamine-containing neurons. J. Comp. Neurol., 301, 604-617.
43. RADEMACHER, D.J., PATEL, S., HOPP, F.A., DEAN, C., HILLARD, C.J. & SEAGARD, J.L. (2003). Microinjection of a cannabinoid receptor antagonist into the NTS increases baroreflex duration in dogs. Am. J. Physiol. Heart Circ. Physiol., 284, H1570-H1576.
44. SALIO, C., FISCHER, J., FOSCA FRANZONI, M., MACKIE, K., KANEKO, T. & CONRATH, M. (2001). CB1-cannabinoid and muopioid receptor co-localization on postsynaptic target in the rat dorsal horn. Neuroreport, 12, 3689-3692.
45. SCHREIHOFER, A.M., STORNETTA, R.L. & GUYENET, P.G. (1999). Evidence for glycinergic respiratory neurons: Botzinger neurons express mRNA for glycinergic transporter 2. J. Comp. Neural., 407, 583-597.
46. SMITH, P.J.W. & McQUEEN, D.S. (2001). Anandamide induces cardiovascular and respiratory reflexes via vasosensory nerves in the anaesthetised rat. Br. J. Pharmacol., 134, 655-663.
47. SUN, Q.-J., GOODCHILD, A.K., CHALMERS, J. & PILOWSKY, P.M. (1998). The pre-Botzinger complex and phase-spanning neurons in the adult rat. Brain Res., 809, 204-213.
48. SZABO, B., PFITZER, T. & NIEDERHOFFER, N. (2002). Central respiratory effects of cannabinoids in rats. Conference Proceedings, 12th Annual Symposium on the Cannabinoids, California, U.S.A.
49. TSOU, K., BROWN, S., SANUDO-PENA, M.C., MACKIE, K. & WALKER, J.M. (1998). Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience, 83, 393-411.
50. VAUGHAN, C.W., CONNOR, M., BAGLEY, E. & CHRISTIE, M.J. (2000). Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal grey neurons in vitro. Mol. Pharmacol., 57, 288-295.
51. VAUGHAN, C.W., McGREGOR, I.S. & CHRISTIE, M.J. (1999). Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventrolateral medulla neurons in vitro. Br. J. Pharmacol., 127, 935-940.
52. VOLLMER, R.R., CAVERO, I., ERTEL, R.J., SOLOMON, T. & BUCKLEY, J.P. (1974). Role of the central autonomie nervous system in the hypotension and bradycardia induced by (-)-delta-9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther., 26, 186-192.